EditorialsBarriers and Research Priorities for Implementing Precision MedicineWhitcomb, David C. MD, PhDAuthor Information From the Departments of Medicine, Cell Biology and Molecular Physiology, and Human Genetics, University of Pittsburgh, Pittsburgh, PA. Address correspondence to: David C. Whitcomb, MD, PhD, Departments of Medicine, Cell Biology & Molecular Physiology, and Human Genetics, Division of Gastroenterology, Hepatology and Nutritions, University of Pittsburgh, Room 401.4, 3708 Fifth Ave, Pittsburgh, PA 15213 (e-mail: firstname.lastname@example.org). D.C.W. is funded by NIH DK061451, U01 DK108306, and the Department of Defense (W81XWH-17-1-0502). He serves as a consultant to AbbVie, Abbott (India), Ariel Precision Medicine, Regeneron, and Samsung (Korea). He is a cofounder of Ariel Precision Medicine and may have equity. Pancreas: 11/12 2019 - Volume 48 - Issue 10 - p 1246-1249 doi: 10.1097/MPA.0000000000001415 Buy Metrics Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.